Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LipoCol Forte and Nifedipine Pharmacokinetics in Healthy Subjects
NCT01346657Phase 4Completed
- Sponsor
- Taipei Medical University WanFang Hospital
- Start
- Jul 2009
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hypertension (HTN) and hypercholesterolemia comparing Nifedipine alone with Nifedipine + LipoCol Forte (2 arms). Primary endpoint: Pharmacokinetic parameters of nifedipine at 1 week. Started Jul 2009; status: completed.
02
Drugs
LipoCol Fortenifedipine
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT01346657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01346657.